Patients currently on Zepbound can transition to PlexusDx compounded tirzepatide at their current dose without interruption
Lhteenvuo M, Tiihonen J, Solismaa A, et al
Nausea, diarrhea, vomiting, constipation, and dyspepsia are documented in clinical trials, with higher doses generally associated with increased frequency and severity of these symptoms
The researchers hypothesized that rapid correction of hyperglycemia induced by these drugs, rather than direct toxicity of the medications, could be associated with the reported ophthalmic complications
(2019) 42(Suppl 1):S90102
When to Contact Your Doctor Regular check-ins allow your provider to monitor lab work, adjust dosage, and ensure the treatment remains safe and effective